...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism

The Phase 2 clinical trial that studied the effects of RVX-208 on glucose metabolism in individuals with pre-diabetes (NCT01728467) is now published.

Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism in individuals with prediabetes: A randomized controlled trial.

Share
New Message
Please login to post a reply